Crux Biomedical Receives $8,000,000 Series B Funding Round

  • Feed Type
  • Date
  • Company Name
    Crux Biomedical
  • Mailing Address
    1455 Adams Drive Menlo Park, CA 94025
  • Company Description
    The company is developing a retrievable Inferior Vena Cava (IVC) filter that promises to be a great improvement over existing modes of treatment. The device has been successfully tested in animal studies in
    2006 and was recently implanted in humans. Crux is currently working with the FDA to design and implement large-scale human clinical trials.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy